As of Nov 13, 2026. At least 3 observations, ranked by Alpha IQ over 21 trading days. 1,918 eligible records before the optional luck filter.
Link an account to see your stake.
#1 Chang Liu
13 buys · 0 sales · 21 trading days
Alpha IQ90.2
Why this rank?
12 of 13 worked
Luck not ruled out
Luck could explain this record.
This rank comes from 13 purchases and 0 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
13 trade dates · 2 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought YQAug 21, 2026$2,079
Stock +49.4%; recorded comparison +0.6%; outcome in the trade's direction +48.8%.
1 reported line and filing sources
Aug 21, 2026 · $2,079 · Form 4Stock +49.4% versus SPY +0.6%.
Bought YQJul 2, 2026$41,753
Stock -19.3%; recorded comparison +2.5%; outcome in the trade's direction -21.7%.
1 reported line and filing sources
Jul 2, 2026 · $41,753 · Form 4Stock -19.3% versus SPY +2.5%.
Bought YQJul 17, 2026$15,887
Stock +17.8%; recorded comparison +2.8%; outcome in the trade's direction +15.0%.
1 reported line and filing sources
Jul 17, 2026 · $15,887 · Form 4Stock +17.8% versus SPY +2.8%.
Bought YQAug 13, 2026$2,054
Stock +54.2%; recorded comparison -2.9%; outcome in the trade's direction +57.1%.
1 reported line and filing sources
Aug 13, 2026 · $2,054 · Form 4Stock +54.2% versus SPY -2.9%.
Bought YQAug 28, 2026$8,432
Stock +74.5%; recorded comparison +0.3%; outcome in the trade's direction +74.2%.
1 reported line and filing sources
Aug 28, 2026 · $8,432 · Form 4Stock +74.5% versus SPY +0.3%.
Bought YQAug 26, 2026$19,927
Stock +74.1%; recorded comparison -0.7%; outcome in the trade's direction +74.8%.
1 reported line and filing sources
Aug 26, 2026 · $19,927 · Form 4Stock +74.1% versus SPY -0.7%.
Bought YQSep 2, 2026$19,819
Stock +20.6%; recorded comparison +0.2%; outcome in the trade's direction +20.4%.
1 reported line and filing sources
Sep 2, 2026 · $19,819 · Form 4Stock +20.6% versus SPY +0.2%.
Bought YQSep 3, 2026$23,788
Stock +15.1%; recorded comparison -24.2%; outcome in the trade's direction +39.2%.
1 reported line and filing sources
Sep 3, 2026 · $23,788 · Form 4Stock +15.1% versus the recorded factor comparison -24.2%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001843196. Profile company CIK 0001821468. 17 Education & Technology Group Inc.
Recorded role: Chief Executive Officer · YQ.
13 obs. Confidence 80; 21-day hit rate 92.3%. Confidence measures the sample, not a probability of future success.
Luck reference: 12 of 13 represented trade dates; upper tail 4.394e-4; corrected within the horizon 2.988e-1, across 24734 person/horizon comparisons 1.647e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 1 wins and upper tail 6.898e-1.
This rank comes from 72 purchases and 9 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
132 trade dates · 18 nonoverlapping windows · 7 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought CDXSApr 8, 2025$198,380
Stock +6.5%; recorded comparison +23.4%; outcome in the trade's direction -17.0%.
1 reported line and filing sources
Apr 8, 2025 · $198,380 · Form 4Stock +6.5% versus the recorded factor comparison +23.4%.
Bought CDXSApr 30, 2025$57,660
Stock -7.1%; recorded comparison +3.1%; outcome in the trade's direction -10.3%.
1 reported line and filing sources
Apr 30, 2025 · $57,660 · Form 4Stock -7.1% versus the recorded factor comparison +3.1%.
Bought HROWApr 23, 2024$120,547
Stock +70.4%; recorded comparison +45.3%; outcome in the trade's direction +25.1%.
1 reported line and filing sources
Apr 23, 2024 · $120,547 · Form 4Stock +70.4% versus the recorded factor comparison +45.3%.
Bought CDXSMar 20, 2025$236,284
Stock -25.7%; recorded comparison -8.8%; outcome in the trade's direction -16.9%.
2 reported lines and filing sources
Mar 20, 2025 · $18 · Form 4Stock -25.7% versus the recorded factor comparison -8.8%.
Mar 21, 2025 · $236,266 · Form 4Stock -25.7% versus the recorded factor comparison -8.8%.
Bought CDXSMar 13, 2025$216,155
Stock -17.3%; recorded comparison -16.6%; outcome in the trade's direction -0.7%.
1 reported line and filing sources
Mar 13, 2025 · $216,155 · Form 4Stock -17.3% versus the recorded factor comparison -16.6%.
Bought SLGLNov 24, 2025$37,933
Stock +9.5%; recorded comparison +1.2%; outcome in the trade's direction +8.3%.
2 reported lines and filing sources
Nov 26, 2025 · $37,720 · Form 4Stock +9.5% versus SPY +1.2%.
Nov 24, 2025 · $213 · Form 4Stock +9.5% versus SPY +1.2%.
Bought CDXSJul 29, 2025$28,161
Stock +1.9%; recorded comparison +3.4%; outcome in the trade's direction -1.6%.
2 reported lines and filing sources
Jul 30, 2025 · $4,411 · Form 4Stock +1.9% versus the recorded factor comparison +3.4%.
Jul 29, 2025 · $23,750 · Form 4Stock +1.9% versus the recorded factor comparison +3.4%.
Bought HROWNov 15, 2023$200,735
Stock +14.9%; recorded comparison +21.0%; outcome in the trade's direction -6.1%.
1 reported line and filing sources
Nov 15, 2023 · $200,735 · Form 4Stock +14.9% versus the recorded factor comparison +21.0%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001595855. Profile company CIK 0001417663. SANUWAVE Health, Inc.
Recorded role: 10% Owner · SNVW.
81 obs. Confidence 100; 21-day hit rate 72.8%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 121.3):
Past calls: 58% directionally correct over 3 months (adjusted toward 50% peer prior; 59% observed; recency-weighted sample 121.3)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 58 of 78 represented trade dates; upper tail 1.648e-7; corrected within the horizon 1.009e-3, across 24734 person/horizon comparisons 1.359e-3. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 18 windows, with 12 wins and upper tail 6.011e-2.
This rank comes from 21 purchases and 0 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
24 trade dates · 5 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought GLSIJan 10, 2025$31,275
Stock -2.4%; recorded comparison -12.8%; outcome in the trade's direction +10.4%.
1 reported line and filing sources
Jan 10, 2025 · $31,275 · Form 4Stock -2.4% versus the recorded factor comparison -12.8%.
Bought GLSIJan 6, 2025$39,391
Stock -8.4%; recorded comparison -14.4%; outcome in the trade's direction +6.0%.
2 reported lines and filing sources
Jan 6, 2025 · $14,641 · Form 4Stock -8.4% versus the recorded factor comparison -14.4%.
Jan 7, 2025 · $24,750 · Form 4Stock -8.4% versus the recorded factor comparison -14.4%.
Bought GLSIJan 3, 2025$44,030
Stock -10.2%; recorded comparison -12.5%; outcome in the trade's direction +2.3%.
1 reported line and filing sources
Jan 3, 2025 · $44,030 · Form 4Stock -10.2% versus the recorded factor comparison -12.5%.
Bought GLSIJan 2, 2025$23,940
Stock -4.7%; recorded comparison -9.8%; outcome in the trade's direction +5.1%.
1 reported line and filing sources
Jan 2, 2025 · $23,940 · Form 4Stock -4.7% versus the recorded factor comparison -9.8%.
Bought GLSIDec 31, 2024$27,264
Stock -0.8%; recorded comparison -2.6%; outcome in the trade's direction +1.8%.
1 reported line and filing sources
Dec 31, 2024 · $27,264 · Form 4Stock -0.8% versus the recorded factor comparison -2.6%.
Bought GLSIDec 30, 2024$35,584
Stock +8.0%; recorded comparison +5.0%; outcome in the trade's direction +3.0%.
1 reported line and filing sources
Dec 30, 2024 · $35,584 · Form 4Stock +8.0% versus the recorded factor comparison +5.0%.
Bought GLSIApr 25, 2025$35,568
Stock -4.2%; recorded comparison +10.3%; outcome in the trade's direction -14.6%.
1 reported line and filing sources
Apr 25, 2025 · $35,568 · Form 4Stock -4.2% versus the recorded factor comparison +10.3%.
Bought GLSIApr 17, 2025$48,492
Stock +1.0%; recorded comparison +18.1%; outcome in the trade's direction -17.1%.
1 reported line and filing sources
Apr 17, 2025 · $48,492 · Form 4Stock +1.0% versus the recorded factor comparison +18.1%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001806920. Profile company CIK 0001799788. Greenwich LifeSciences, Inc.
Recorded role: CEO · GLSI.
21 obs. Confidence 93; 21-day hit rate 81.0%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 17.2):
Past calls: 51% directionally correct over 3 months (adjusted toward 50% peer prior; 52% observed; recency-weighted sample 17.2)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 17 of 21 represented trade dates; upper tail 6.750e-4; corrected within the horizon 3.443e-1, across 24734 person/horizon comparisons 2.009e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 5 windows, with 4 wins and upper tail 1.244e-1.
This rank comes from 12 purchases and 0 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
12 trade dates · 7 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought RZLTMar 26, 2025$57,700
Stock +31.7%; recorded comparison +31.0%; outcome in the trade's direction +0.7%.
2 reported lines and filing sources
Mar 26, 2025 · $28,800 · Form 4Stock +31.7% versus the recorded factor comparison +31.0%.
Mar 26, 2025 · $28,900 · Form 4Stock +31.7% versus the recorded factor comparison +31.0%.
Bought RZLTJun 24, 2025$20,250
Stock +38.4%; recorded comparison +28.4%; outcome in the trade's direction +10.1%.
1 reported line and filing sources
Jun 24, 2025 · $20,250 · Form 4Stock +38.4% versus the recorded factor comparison +28.4%.
Bought RZLTMar 15, 2024$33,830
Stock +73.7%; recorded comparison +34.5%; outcome in the trade's direction +39.2%.
1 reported line and filing sources
Mar 15, 2024 · $33,830 · Form 4Stock +73.7% versus the recorded factor comparison +34.5%.
Bought RZLTMar 8, 2024$96,345
Stock +31.6%; recorded comparison +10.1%; outcome in the trade's direction +21.5%.
1 reported line and filing sources
Mar 8, 2024 · $96,345 · Form 4Stock +31.6% versus the recorded factor comparison +10.1%.
Bought RZLTFeb 16, 2024$54,411
Stock +31.7%; recorded comparison +3.8%; outcome in the trade's direction +27.9%.
1 reported line and filing sources
Feb 16, 2024 · $54,411 · Form 4Stock +31.7% versus the recorded factor comparison +3.8%.
Bought RZLTDec 18, 2024$42,900
Stock +17.9%; recorded comparison +3.3%; outcome in the trade's direction +14.6%.
1 reported line and filing sources
Dec 18, 2024 · $42,900 · Form 4Stock +17.9% versus the recorded factor comparison +3.3%.
Bought RZLTJun 14, 2024$161,568
Stock +17.5%; recorded comparison +11.6%; outcome in the trade's direction +5.9%.
1 reported line and filing sources
Jun 14, 2024 · $161,568 · Form 4Stock +17.5% versus the recorded factor comparison +11.6%.
Bought RZLTDec 12, 2024$41,400
Stock +0.2%; recorded comparison -12.2%; outcome in the trade's direction +12.4%.
1 reported line and filing sources
Dec 12, 2024 · $41,400 · Form 4Stock +0.2% versus the recorded factor comparison -12.2%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001411726. Profile company CIK 0001509261. Rezolute, Inc.
Recorded role: CFO · RZLT.
12 obs. Confidence 78; 21-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 12 of 12 represented trade dates; upper tail 5.719e-5; corrected within the horizon 1.750e-1, across 24734 person/horizon comparisons 5.894e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 7 windows, with 7 wins and upper tail 3.350e-3.
This rank comes from 1 purchases and 16 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
22 trade dates · 6 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought SPOKJun 16, 2026$1,100,115
Stock +3.3%; recorded comparison -0.7%; outcome in the trade's direction +4.0%.
3 reported lines and filing sources
Jun 16, 2026 · $366,705 · Form 4Stock +3.3% versus the recorded factor comparison -0.7%.
Jun 16, 2026 · $366,705 · Form 4Stock +3.3% versus the recorded factor comparison -0.7%.
Jun 16, 2026 · $366,705 · Form 4Stock +3.3% versus the recorded factor comparison -0.7%.
Sold SPOKAug 22, 2025
Stock -2.9%; recorded comparison +7.0%; outcome in the trade's direction +9.9%.
Some reported source details are unavailable.
5 reported lines and filing sources
Aug 25, 2025 · $97,150 · Form 4Stock -2.9% versus the recorded factor comparison +7.0%.
Aug 22, 2025 · $73,567 · Form 4Stock -2.9% versus the recorded factor comparison +7.0%.
Aug 25, 2025 · $114,059 · Form 4Stock -2.9% versus the recorded factor comparison +7.0%.
Aug 22, 2025 · $86,357 · Form 4Stock -2.9% versus the recorded factor comparison +7.0%.
Aug 25, 2025 · Form 4Stock -2.9% versus the recorded factor comparison +7.0%.
Sold SPOKAug 20, 2025
Stock -2.5%; recorded comparison +6.4%; outcome in the trade's direction +8.9%.
Some reported source details are unavailable.
3 reported lines and filing sources
Aug 20, 2025 · $129,083 · Form 4Stock -2.5% versus the recorded factor comparison +6.4%.
Aug 20, 2025 · $109,970 · Form 4Stock -2.5% versus the recorded factor comparison +6.4%.
Aug 20, 2025 · Form 4Stock -2.5% versus the recorded factor comparison +6.4%.
Sold SPOKAug 18, 2025
Stock -3.0%; recorded comparison +6.9%; outcome in the trade's direction +9.9%.
Some reported source details are unavailable.
3 reported lines and filing sources
Aug 18, 2025 · $239,692 · Form 4Stock -3.0% versus the recorded factor comparison +6.9%.
Aug 18, 2025 · Form 4Stock -3.0% versus the recorded factor comparison +6.9%.
Aug 18, 2025 · $281,353 · Form 4Stock -3.0% versus the recorded factor comparison +6.9%.
Sold SPOKMar 4, 2024$234,600
Stock -9.0%; recorded comparison -2.7%; outcome in the trade's direction +6.4%.
1 reported line and filing sources
Mar 4, 2024 · $234,600 · Form 4Stock -9.0% versus the recorded factor comparison -2.7%.
Sold SPOKFeb 29, 2024$113,726
Stock -9.3%; recorded comparison -6.2%; outcome in the trade's direction +3.1%.
1 reported line and filing sources
Feb 29, 2024 · $113,726 · Form 4Stock -9.3% versus the recorded factor comparison -6.2%.
Sold SPOKFeb 27, 2024$425,950
Stock -12.4%; recorded comparison -7.3%; outcome in the trade's direction +5.1%.
1 reported line and filing sources
Feb 27, 2024 · $425,950 · Form 4Stock -12.4% versus the recorded factor comparison -7.3%.
Sold SPOKAug 14, 2025
Stock -4.3%; recorded comparison +1.7%; outcome in the trade's direction +6.0%.
Some reported source details are unavailable.
5 reported lines and filing sources
Aug 14, 2025 · $350,682 · Form 4Stock -4.3% versus the recorded factor comparison +1.7%.
Aug 15, 2025 · $283,394 · Form 4Stock -4.3% versus the recorded factor comparison +1.7%.
Aug 14, 2025 · $817,887 · Form 4Stock -4.3% versus the recorded factor comparison +1.7%.
Aug 15, 2025 · $332,654 · Form 4Stock -4.3% versus the recorded factor comparison +1.7%.
Aug 15, 2025 · Form 4Stock -4.3% versus the recorded factor comparison +1.7%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001747745. Profile company CIK 0001289945. Spok Holdings, Inc
Recorded role: Director · SPOK.
17 obs. Confidence 88; 21-day hit rate 88.2%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 19.8):
Past calls: 66% directionally correct over 3 months (adjusted toward 50% peer prior; 85% observed; recency-weighted sample 19.8)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 15 of 17 represented trade dates; upper tail 2.004e-3; corrected within the horizon 5.842e-1, across 24734 person/horizon comparisons 3.645e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 6 windows, with 5 wins and upper tail 1.205e-1.
This rank comes from 9 purchases and 1 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
16 trade dates · 3 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought SBGIMar 21, 2025$1,879,514
Stock -13.4%; recorded comparison -27.6%; outcome in the trade's direction +14.2%.
2 reported lines and filing sources
Mar 24, 2025 · $294,422 · Form 4Stock -13.4% versus the recorded factor comparison -27.6%.
Mar 21, 2025 · $1,585,092 · Form 4Stock -13.4% versus the recorded factor comparison -27.6%.
Bought SBGIMar 20, 2025$75,897
Stock -15.9%; recorded comparison -25.7%; outcome in the trade's direction +9.8%.
1 reported line and filing sources
Mar 20, 2025 · $75,897 · Form 4Stock -15.9% versus the recorded factor comparison -25.7%.
Bought SBGIMar 18, 2025$1,046,346
Stock -17.2%; recorded comparison -26.8%; outcome in the trade's direction +9.5%.
2 reported lines and filing sources
Mar 18, 2025 · $972,602 · Form 4Stock -17.2% versus the recorded factor comparison -26.8%.
Mar 19, 2025 · $73,744 · Form 4Stock -17.2% versus the recorded factor comparison -26.8%.
Bought SBGIMar 12, 2025$599,657
Stock -3.0%; recorded comparison -17.5%; outcome in the trade's direction +14.5%.
1 reported line and filing sources
Mar 12, 2025 · $599,657 · Form 4Stock -3.0% versus the recorded factor comparison -17.5%.
Bought SBGIMar 10, 2025$1,493,236
Stock -7.9%; recorded comparison -22.3%; outcome in the trade's direction +14.4%.
2 reported lines and filing sources
Mar 11, 2025 · $555,987 · Form 4Stock -7.9% versus the recorded factor comparison -22.3%.
Mar 10, 2025 · $937,249 · Form 4Stock -7.9% versus the recorded factor comparison -22.3%.
Bought SBGIMar 6, 2025$324,828
Stock -3.1%; recorded comparison -22.7%; outcome in the trade's direction +19.6%.
1 reported line and filing sources
Mar 6, 2025 · $324,828 · Form 4Stock -3.1% versus the recorded factor comparison -22.7%.
Bought SBGIMar 3, 2025$538,243
Stock +18.7%; recorded comparison +6.6%; outcome in the trade's direction +12.1%.
1 reported line and filing sources
Mar 3, 2025 · $538,243 · Form 4Stock +18.7% versus the recorded factor comparison +6.6%.
Bought SBGIApr 8, 2025$2,481,355
Stock +20.5%; recorded comparison +30.3%; outcome in the trade's direction -9.8%.
2 reported lines and filing sources
Apr 9, 2025 · $814,083 · Form 4Stock +20.5% versus the recorded factor comparison +30.3%.
Apr 8, 2025 · $1,667,272 · Form 4Stock +20.5% versus the recorded factor comparison +30.3%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001642280. Profile company CIK 0001273441. GRAN TIERRA ENERGY INC.
Recorded role: Director · GTE.
10 obs. Confidence 71; 21-day hit rate 90.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 9 of 10 represented trade dates; upper tail 4.570e-3; corrected within the horizon 9.608e-1, across 24734 person/horizon comparisons 6.013e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 3 windows, with 3 wins and upper tail 1.032e-1.
This rank comes from 10 purchases and 0 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
13 trade dates · 3 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought ENOVMar 13, 2026$23,740
Stock +9.1%; recorded comparison +7.1%; outcome in the trade's direction +2.0%.
1 reported line and filing sources
Mar 13, 2026 · $23,740 · Form 4Stock +9.1% versus the recorded factor comparison +7.1%.
Bought ENOVMar 10, 2026$23,930
Stock +6.3%; recorded comparison +0.5%; outcome in the trade's direction +5.8%.
1 reported line and filing sources
Mar 10, 2026 · $23,930 · Form 4Stock +6.3% versus the recorded factor comparison +0.5%.
Bought ENOVMar 6, 2026$41,700
Stock +0.5%; recorded comparison -6.2%; outcome in the trade's direction +6.7%.
3 reported lines and filing sources
Mar 9, 2026 · $23,390 · Form 4Stock +0.5% versus the recorded factor comparison -6.2%.
Mar 6, 2026 · $12,240 · Form 4Stock +0.5% versus the recorded factor comparison -6.2%.
Mar 6, 2026 · $6,070 · Form 4Stock +0.5% versus the recorded factor comparison -6.2%.
Bought ENOVMar 3, 2026$31,045
Stock -6.4%; recorded comparison -12.6%; outcome in the trade's direction +6.1%.
2 reported lines and filing sources
Mar 3, 2026 · $24,770 · Form 4Stock -6.4% versus the recorded factor comparison -12.6%.
Mar 4, 2026 · $6,275 · Form 4Stock -6.4% versus the recorded factor comparison -12.6%.
Bought ENOVJun 15, 2026$20,920
Stock +25.4%; recorded comparison +1.5%; outcome in the trade's direction +23.9%.
1 reported line and filing sources
Jun 15, 2026 · $20,920 · Form 4Stock +25.4% versus the recorded factor comparison +1.5%.
Bought ENOVJun 11, 2026$25,948
Stock +33.8%; recorded comparison +1.8%; outcome in the trade's direction +32.0%.
2 reported lines and filing sources
Jun 11, 2026 · $21,750 · Form 4Stock +33.8% versus the recorded factor comparison +1.8%.
Jun 11, 2026 · $4,198 · Form 4Stock +33.8% versus the recorded factor comparison +1.8%.
Bought ENOVJun 10, 2026$23,000
Stock +16.7%; recorded comparison -3.7%; outcome in the trade's direction +20.4%.
1 reported line and filing sources
Jun 10, 2026 · $23,000 · Form 4Stock +16.7% versus the recorded factor comparison -3.7%.
Bought ENOVJun 1, 2026$22,220
Stock +20.1%; recorded comparison +10.0%; outcome in the trade's direction +10.2%.
1 reported line and filing sources
Jun 1, 2026 · $22,220 · Form 4Stock +20.1% versus the recorded factor comparison +10.0%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0002105870. Profile company CIK 0001420800. Enovis CORP
Recorded role: Chief Administrative Officer · ENOV.
10 obs. Confidence 71; 21-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 10.3):
Past calls: 35% directionally correct over 3 months (adjusted toward 50% peer prior; 0% observed; recency-weighted sample 10.3)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 10 of 10 represented trade dates; upper tail 2.913e-4; corrected within the horizon 2.229e-1, across 24734 person/horizon comparisons 1.360e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 3 windows, with 3 wins and upper tail 8.696e-2.
This rank comes from 15 purchases and 0 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
15 trade dates · 4 nonoverlapping windows · 3 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought AIRSMar 23, 2026$145,500
Stock -20.0%; recorded comparison -10.7%; outcome in the trade's direction -9.3%.
1 reported line and filing sources
Mar 23, 2026 · $145,500 · Form 4Stock -20.0% versus the recorded factor comparison -10.7%.
Bought AIRSMar 20, 2026$110,800
Stock -3.6%; recorded comparison -12.6%; outcome in the trade's direction +9.0%.
1 reported line and filing sources
Mar 20, 2026 · $110,800 · Form 4Stock -3.6% versus the recorded factor comparison -12.6%.
Bought AIRSMar 19, 2026$205,133
Stock -7.5%; recorded comparison -12.6%; outcome in the trade's direction +5.1%.
1 reported line and filing sources
Mar 19, 2026 · $205,133 · Form 4Stock -7.5% versus the recorded factor comparison -12.6%.
Bought AIRSMar 17, 2026$212,480
Stock -8.2%; recorded comparison -7.2%; outcome in the trade's direction -1.0%.
1 reported line and filing sources
Mar 17, 2026 · $212,480 · Form 4Stock -8.2% versus the recorded factor comparison -7.2%.
Bought AIRSMar 16, 2026$257,211
Stock -0.5%; recorded comparison -7.0%; outcome in the trade's direction +6.5%.
1 reported line and filing sources
Mar 16, 2026 · $257,211 · Form 4Stock -0.5% versus the recorded factor comparison -7.0%.
Bought AIRSMar 11, 2026$189,200
Stock +16.8%; recorded comparison -27.2%; outcome in the trade's direction +44.0%.
1 reported line and filing sources
Mar 11, 2026 · $189,200 · Form 4Stock +16.8% versus the recorded factor comparison -27.2%.
Bought AIRSMar 6, 2026$91,200
Stock +32.0%; recorded comparison -17.1%; outcome in the trade's direction +49.1%.
1 reported line and filing sources
Mar 6, 2026 · $91,200 · Form 4Stock +32.0% versus the recorded factor comparison -17.1%.
Bought AIRSMar 3, 2026$192,900
Stock +72.8%; recorded comparison -0.7%; outcome in the trade's direction +73.4%.
2 reported lines and filing sources
Mar 4, 2026 · $56,100 · Form 4Stock +72.8% versus the recorded factor comparison -0.7%.
Mar 3, 2026 · $136,800 · Form 4Stock +72.8% versus the recorded factor comparison -0.7%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0002042077. Profile company CIK 0001274737. EXAGEN INC.
15 obs. Confidence 85; 21-day hit rate 73.3%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 23.2):
Past calls: 57% directionally correct over 3 months (adjusted toward 50% peer prior; 64% observed; recency-weighted sample 23.2)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 10 of 14 represented trade dates; upper tail 3.800e-2; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 4 windows, with 2 wins and upper tail 5.976e-1.
This rank comes from 14 purchases and 0 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
15 trade dates · 4 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought ADVMar 18, 2025$56,678
Stock -25.9%; recorded comparison -9.1%; outcome in the trade's direction -16.8%.
1 reported line and filing sources
Mar 18, 2025 · $56,678 · Form 4Stock -25.9% versus SPY -9.1%.
Bought ADVMar 14, 2025$104,319
Stock -19.4%; recorded comparison -6.3%; outcome in the trade's direction -13.1%.
2 reported lines and filing sources
Mar 17, 2025 · $45,742 · Form 4Stock -19.4% versus SPY -6.3%.
Mar 14, 2025 · $58,577 · Form 4Stock -19.4% versus SPY -6.3%.
Bought ADVJun 6, 2025$12,485
Stock +4.8%; recorded comparison +3.4%; outcome in the trade's direction +1.4%.
1 reported line and filing sources
Jun 6, 2025 · $12,485 · Form 4Stock +4.8% versus SPY +3.4%.
Bought ADVJun 4, 2025$7,103
Stock +22.3%; recorded comparison +4.2%; outcome in the trade's direction +18.1%.
1 reported line and filing sources
Jun 4, 2025 · $7,103 · Form 4Stock +22.3% versus SPY +4.2%.
Bought ADVJun 2, 2025$19,873
Stock +24.0%; recorded comparison +4.2%; outcome in the trade's direction +19.8%.
1 reported line and filing sources
Jun 2, 2025 · $19,873 · Form 4Stock +24.0% versus SPY +4.2%.
Bought ADVMay 29, 2025$14,570
Stock +34.8%; recorded comparison +4.7%; outcome in the trade's direction +30.1%.
1 reported line and filing sources
May 29, 2025 · $14,570 · Form 4Stock +34.8% versus SPY +4.7%.
Bought ADVMay 28, 2025$12,706
Stock +6.5%; recorded comparison +4.7%; outcome in the trade's direction +1.7%.
1 reported line and filing sources
May 28, 2025 · $12,706 · Form 4Stock +6.5% versus SPY +4.7%.
Bought ADVMay 23, 2025$15,977
Stock +5.6%; recorded comparison +4.6%; outcome in the trade's direction +1.0%.
1 reported line and filing sources
May 23, 2025 · $15,977 · Form 4Stock +5.6% versus SPY +4.6%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001025094. Profile company CIK 0001792044. Viatris Inc
Recorded role: Director · VTRS.
14 obs. Confidence 83; 21-day hit rate 78.6%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 11.1):
Past calls: 58% directionally correct over 3 months (adjusted toward 50% peer prior; 76% observed; recency-weighted sample 11.1)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 11 of 14 represented trade dates; upper tail 9.941e-3; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 7.961e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 4 windows, with 2 wins and upper tail 5.976e-1.
This rank comes from 14 purchases and 0 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
14 trade dates · 4 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought KALVJan 30, 2025$382,873
Stock +25.9%; recorded comparison +9.8%; outcome in the trade's direction +16.2%.
1 reported line and filing sources
Jan 30, 2025 · $382,873 · Form 4Stock +25.9% versus the recorded factor comparison +9.8%.
Bought KALVFeb 20, 2024$9,999,349
Stock -5.8%; recorded comparison +4.3%; outcome in the trade's direction -10.1%.
1 reported line and filing sources
Feb 20, 2024 · $9,999,349 · Form 4Stock -5.8% versus the recorded factor comparison +4.3%.
Bought KALVJan 25, 2024$89,492
Stock -6.6%; recorded comparison -6.7%; outcome in the trade's direction +0.1%.
1 reported line and filing sources
Jan 25, 2024 · $89,492 · Form 4Stock -6.6% versus the recorded factor comparison -6.7%.
Bought KALVFeb 7, 2025$684,199
Stock +32.1%; recorded comparison +5.1%; outcome in the trade's direction +27.1%.
1 reported line and filing sources
Feb 7, 2025 · $684,199 · Form 4Stock +32.1% versus the recorded factor comparison +5.1%.
Bought KALVJan 22, 2024$847,702
Stock +3.5%; recorded comparison -4.8%; outcome in the trade's direction +8.2%.
1 reported line and filing sources
Jan 22, 2024 · $847,702 · Form 4Stock +3.5% versus the recorded factor comparison -4.8%.
Bought KALVDec 27, 2023$496,923
Stock +28.7%; recorded comparison +5.3%; outcome in the trade's direction +23.5%.
1 reported line and filing sources
Dec 27, 2023 · $496,923 · Form 4Stock +28.7% versus the recorded factor comparison +5.3%.
Bought KALVJan 8, 2024$860,649
Stock +25.9%; recorded comparison +9.6%; outcome in the trade's direction +16.3%.
1 reported line and filing sources
Jan 8, 2024 · $860,649 · Form 4Stock +25.9% versus the recorded factor comparison +9.6%.
Bought KALVFeb 12, 2025$923,000
Stock +26.7%; recorded comparison -0.2%; outcome in the trade's direction +27.0%.
1 reported line and filing sources
Feb 12, 2025 · $923,000 · Form 4Stock +26.7% versus the recorded factor comparison -0.2%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001738048. Profile company CIK 0000907654. Oruka Therapeutics, Inc.
14 obs. Confidence 83; 21-day hit rate 71.4%. Confidence measures the sample, not a probability of future success.
Luck reference: 10 of 14 represented trade dates; upper tail 3.800e-2; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 4 windows, with 2 wins and upper tail 5.976e-1.
One entry per filing selected from the current 90-day scored feed. Derivatives and known open-market trades below $10,000 are excluded from conviction scoring. These are reported transactions, not live trades. A trade score and an insider's historical Alpha IQ measure different things.